CooperCompanies to Present at KeyBanc Life Sciences & MedTech Investor Forum
CooperCompanies (NYSE: COO) will participate in the KeyBanc Life Sciences & MedTech Investor Forum on March 21, 2022.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
CooperCompanies (NYSE: COO) will participate in the KeyBanc Life Sciences & MedTech Investor Forum on March 21, 2022. Brian Andrews, the Executive Vice President and CFO, will represent the company in a virtual session starting at 1:30 PM ET. Investors can access the live webcast on CooperCompanies' official website, with a replay available afterward. With a workforce exceeding 14,000, CooperCompanies operates through two main units: CooperVision, focusing on vision care products, and CooperSurgical, which specializes in women's health and fertility. The company serves markets in over 100 countries.
Details
News Market Reaction – COO
The recorded move for COO in the trading session of this news was -1.04%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SAN RAMON, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will participate in KeyBanc’s Life Sciences & MedTech Investor Forum on Tuesday, March 21, 2022. Brian Andrews, Executive Vice President, Chief Financial Officer & Treasurer, will represent the Company in a virtual session scheduled to begin at 1:30 PM ET.
The webcast will be available to investors and other interested parties by accessing the CooperCompanies’ website at http://investor.coopercos.com. A replay of the event will be available on the same webpage following its conclusion.
About CooperCompanies
CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE: COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, CA, Cooper has a workforce of more than 14,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com.
Contact:
Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
ir@cooperco.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.